Legal & Regulatory

Australian Lawmakers Hold Hearing Day on Cannabis Legalization

The Australian Senate's Legal and Constitutional Affairs Legislation Committee held a hearing on the Cannabis Legalization Bill 2023, which proposes the establishment of the Cannabis Australia National Agency and allows for home cultivation and Cannabis Cafés. The bill faces mixed opinions, with advocates emphasizing the failure of prohibition and the need for a fair regulatory framework.

Last week, the Australian Senate’s Legal and Constitutional Affairs Legislation Committee held its first hearing on the legalization of adult use of cannabis.

Lawmakers in Brisbane heard arguments for and against the Cannabis Legalization Bill 2023 proposed by Green Senator David Shoebridge. It includes the establishment of the Cannabis Australia National Agency, a statutory body responsible for registering cannabis strains and regulating cannabis-related activities, and would allow Australians to grow six plants at home. Cannabis Cafés would also be authorized.

Australia legalized medical cannabis in 2016, and a kind of legislative patchwork has emerged in Australia’s eight states regarding penalties for non-medical use.

For more news like this, along with all the latest in legalization, research, and lifestyle, download our free cannabis news app.

Advocacy and Opposition

Proponents of cannabis legalization argue that prohibition has failed to curb its consumption and has led to disproportionate law enforcement, particularly impacting marginalized communities.

Greg Barns, former president of the Australian Lawyers Alliance, stressed the need to address disparities in law enforcement and highlighted the inconsistency of criminalizing cannabis while alcohol remains legal. He cited international examples, such as Canada and some U.S. states, where legalization has produced positive outcomes and reduced criminalization.

Business Challenges and Regulatory Framework

Malini Sietaram, CEO of Ganjika Pty Ltd, presented a business perspective, pointing out the challenges faced by entrepreneurs in the medical cannabis industry due to regulatory constraints. Sietaram emphasized the need for a regulatory framework that fosters innovation and inclusion, especially for underrepresented groups.

Health and Societal Concerns

Concerns were also expressed about the potential effects of cannabis legalization on health and society. The Australian Medical Association voiced reservations, citing insufficient evidence to support recreational legalization and highlighting the risk of self-medication without medical supervision. Additionally, the Home Affairs Department expressed operational concerns, including border control and customs law enforcement.

Public Opinion and Political Landscape

Australian public opinion is divided on cannabis legalization, with polls showing varying levels of support. While the legalization of cannabis is increasingly accepted, particularly among younger people, it continues to face strong opposition. 50% of Australians are in favor of legalizing home cultivation, while 31% are opposed, and 19% are uncertain. Decriminalization enjoys greater support (54%).

The fate of the Legalising Cannabis Bill 2023 remains uncertain, as it lacks broad political support and faces opposition from major parties, including the ruling party and the Australian Medical Association.

(Featured image by Photoholgic via Unsplash)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Jeremy Whannell

Jeremy Whannell loves writing about the great outdoors, business ventures and tech giants, cryptocurrencies, marijuana stocks, and other investment topics. His proficiency in internet culture rivals his obsession with artificial intelligence and gaming developments. A biker and nature enthusiast, he prefers working and writing out in the wild over an afternoon in a coffee shop.

Recent Posts

2023 Sales of Legal Cannabis in the USA Generated Over $20bn In Taxes

Based on 2023 sales, the United States saw a record high in tax revenues from…

3 days ago

One in Four French Prisoners Smokes Cannabis Daily

A study by the French Observatory of Drugs and Addictions reveals that one in four…

4 days ago

The Fall of an Icon: High Times and the Inevitable Auction of the Iconic Cannabis Brand

High Times, once a leading cannabis culture magazine, faces severe financial troubles, prompting a potential…

5 days ago

DEA Agrees to Reclassify Cannabis as a “Less Dangerous” Substance

The DEA plans to reclassify cannabis from Schedule I to Schedule III of the Controlled…

6 days ago

Pillar 2 Cannabis Pilot Program to Launch in Germany

Germany is advancing its cannabis policy by launching Pillar 2, which involves five-year pilot projects…

1 week ago

Rolling Papers May Contain Traces of Heavy Metals, Study Finds

A new study has revealed that rolling papers can contain heavy metals and chemical residues…

2 weeks ago